Elizabeth Gargon

7.4k total citations · 3 hit papers
40 papers, 4.3k citations indexed

About

Elizabeth Gargon is a scholar working on Sociology and Political Science, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Elizabeth Gargon has authored 40 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Sociology and Political Science, 26 papers in Economics and Econometrics and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Elizabeth Gargon's work include Delphi Technique in Research (34 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers) and Clinical practice guidelines implementation (14 papers). Elizabeth Gargon is often cited by papers focused on Delphi Technique in Research (34 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers) and Clinical practice guidelines implementation (14 papers). Elizabeth Gargon collaborates with scholars based in United Kingdom, Ireland and United States. Elizabeth Gargon's co-authors include Paula Williamson, Mike Clarke, Jane Blazeby, Douglas G. Altman, Sarah L. Gorst, Declan Devane, Peter Tugwell, Jamie J Kirkham, Jochen Schmitt and Bridget Young and has published in prestigious journals such as PLoS ONE, Journal of Clinical Epidemiology and PLoS Medicine.

In The Last Decade

Elizabeth Gargon

39 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The COMET Handbook: version 1.0

2017 1.1k citations Paula Williamson, Douglas G. Altman et al. Trials profile →
Developing core outcome sets for clinical trials: issues to consider

2012 1.1k citations Paula Williamson, Douglas G. Altman et al. Trials profile →
Core Outcome Set–STAndards for Reporting: The COS-STAR Statement

2016 391 citations Jamie J Kirkham, Sarah L. Gorst et al. PLoS Medicine profile →

Peers

Countries citing papers authored by Elizabeth Gargon

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Gargon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Gargon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Gargon more than expected).

Fields of papers citing papers by Elizabeth Gargon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Gargon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Gargon. The network helps show where Elizabeth Gargon may publish in the future.

Co-authorship network of co-authors of Elizabeth Gargon

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Gargon. A scholar is included among the top collaborators of Elizabeth Gargon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Gargon. Elizabeth Gargon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Development and Content Validation of the Sjögren’s Related Quality of Life Instrument (SRQoL) 2024 ·Rheumatology and Therapy ·Jessica Marvel, Elizabeth Gargon, (unknown), (unknown), (unknown), (unknown), Linda Stone, Benjamin A. Fisher, (unknown), Nicola Williamson, Chiara Perella, (unknown)	1
2	A systematic review of studies reporting the development of core outcome sets for use in routine care 2023 ·Journal of Clinical Epidemiology ·Anna Kearney, Elizabeth Gargon, James Mitchell, (unknown), (unknown), Paula Williamson, Susanna Dodd	10
3	Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review 2021 ·BMJ Open ·Jamlick Karumbi, Sarah L. Gorst, David Gathara, Elizabeth Gargon, Bridget Young, Paula Williamson	15
4	Methods used to assess outcome consistency in clinical studies: A literature-based evaluation 2020 ·PLoS ONE ·Ewelina Rogozińska, Elizabeth Gargon, Rocío Olmedo‐Requena, (unknown), N Cooper, Claire L. Vale, Janneke van ’t Hooft	8
5	Improvement was needed in the standards of development for cancer core outcome sets 2019 ·Journal of Clinical Epidemiology ·Elizabeth Gargon, Paula Williamson, Jane Blazeby, Jamie J Kirkham	13
6	Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018 2019 ·The Journal of Rheumatology ·Alessandro Chiarotto, Ulrike Kaiser, Ernest Choy, Robin Christensen, Philip G. Conaghan, (unknown), (unknown), Maarten de Wit, Elizabeth Gargon, (unknown), Jamie J Kirkham, Lee S. Simon, Jasvinder A. Singh, Peter Tugwell, Dennis C. Turk, Philip J. Mease	6
7	Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries 2018 ·PLoS ONE ·Katy Davis, Sarah L. Gorst, Nicola Harman, Valerie Smith, Elizabeth Gargon, Douglas G. Altman, Jane Blazeby, Mike Clarke, Sean Tunis, Paula Williamson	48
8	Higher number of items associated with significantly lower response rates in COS Delphi surveys 2018 ·Journal of Clinical Epidemiology ·Elizabeth Gargon, Richard Crew, Girvan Burnside, Paula Williamson	149
9	Improving core outcome set development: qualitative interviews with developers provided pointers to inform guidance 2017 ·Journal of Clinical Epidemiology ·Elizabeth Gargon, Paula Williamson, Bridget Young	39
10	Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey 2016 ·PLoS ONE ·Sarah L. Gorst, Elizabeth Gargon, Mike Clarke, Jane Blazeby, Douglas G. Altman, Paula Williamson	108
11	Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and Identification of Gaps 2016 ·PLoS ONE ·Sarah L. Gorst, Elizabeth Gargon, Mike Clarke, Valerie Smith, Paula Williamson	58
12	Core Outcome Set–STAndards for Reporting: The COS-STAR Statement breakdown → 2016 ·PLoS Medicine ·Jamie J Kirkham, Sarah L. Gorst, Douglas G. Altman, Jane Blazeby, Mike Clarke, Declan Devane, Elizabeth Gargon, David Moher, Jochen Schmitt, Peter Tugwell, Sean Tunis, Paula Williamson	391
13	COS-STAR: a reporting guideline for studies developing core outcome sets (protocol) 2015 ·Trials ·(unknown), Jamie J Kirkham, Sarah L. Gorst, Douglas G. Altman, Jane Blazeby, Mike Clarke, Declan Devane, Elizabeth Gargon, Paula Williamson	49
14	Collating the knowledge base for core outcome set development: developing and appraising the search strategy for a systematic review 2015 ·BMC Medical Research Methodology ·Elizabeth Gargon, Paula Williamson, Mike Clarke	21
15	Survey of new 2007 and 2011 Cochrane reviews found 37% of prespecified outcomes not reported 2014 ·Journal of Clinical Epidemiology ·Valerie Smith, Mike Clarke, Paula Williamson, Elizabeth Gargon	34
16	Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review 2014 ·PLoS ONE ·Elizabeth Gargon, Binu Gurung, Nancy Medley, Doug Altman, Jane Blazeby, Mike Clarke, Paula Williamson	223
17	Measuring the Symptoms of Pediatric Constipation and Irritable Bowel Syndrome with Constipation: Expert Commentary and Literature Review 2014 ·Patient ·Robert Arbuckle, Robyn T. Carson, Linda Abetz‐Webb, Jeffrey S. Hyams, (unknown), Barbara Edelman Lewis, Elizabeth Gargon, Caroline B. Kurtz, Steven J. Shiff, Jeffrey M. Johnston	5
18	Can a core outcome set improve the quality of systematic reviews? – a survey of the Co-ordinating Editors of Cochrane review groups 2013 ·Trials ·Jamie J Kirkham, Elizabeth Gargon, Mike Clarke, Paula Williamson	136
19	Adverse Drug Reactions in Children—A Systematic Review 2012 ·PLoS ONE ·Rebecca MD Smyth, Elizabeth Gargon, Jamie J Kirkham, Lynne Cresswell, Su Golder, (unknown), (unknown), Paula Williamson	212
20	Developing core outcome sets for clinical trials: issues to consider breakdown → 2012 ·Trials ·Paula Williamson, Douglas G. Altman, Jane Blazeby, Mike Clarke, Declan Devane, Elizabeth Gargon, Peter Tugwell	1096

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact